26
Oct 2026
One in three young adults turns to AI for substance use
More than 32% of participants in a Rutgers study reported using ChatGPT and similar chatbots for substance-use information.
26
Oct 2026
More than 32% of participants in a Rutgers study reported using ChatGPT and similar chatbots for substance-use information.
26
Oct 2026
New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2026 October 22–25.
26
Oct 2026
At a clinic in South Africa, researchers have identified airborne ESKAPE bacteria which survive most antibiotic medicines. The clinic is in a densely populated inner-city area.
26
Oct 2026
Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.
26
Oct 2026
Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026.
25
Oct 2026
Among 3,834 members of weight-management programs, greater recent weight loss was associated with less emotional eating, fewer food cravings, and better mood. Participants identified distraction, meal planning, healthier food swaps, and group support as helpful strategies, but the observational study could not establish whether these approaches caused weight loss.
25
Oct 2026
Researchers analyzed data from 340,924 UK Biobank participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality. Beer/cider and spirits showed associations with higher mortality across several outcomes, whereas low-to-moderate wine consumption was linked to lower mortality for certain outcomes, though the observational study cannot establish causation.
25
Oct 2026
Researchers analyzed data from 340,924 UK Biobank participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality. Beer/cider and spirits showed associations with higher mortality across several outcomes, whereas low-to-moderate wine consumption was linked to lower mortality for certain outcomes, though the observational study cannot establish causation.
25
Oct 2026
Researchers analyzed data from 340,924 UK Biobank participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality. Beer/cider and spirits showed associations with higher mortality across several outcomes, whereas low-to-moderate wine consumption was linked to lower mortality for certain outcomes, though the observational study cannot establish causation.
25
Oct 2026
Researchers reviewed 21 studies involving 24,523 women and found that perimenopausal and postmenopausal women had higher odds of reporting anxiety symptoms than premenopausal women. Their meta-analysis of 15 studies found the highest odds during perimenopause, but the cross-sectional evidence cannot establish that menopause causes anxiety.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more